JP2022550243A5 - - Google Patents
Info
- Publication number
- JP2022550243A5 JP2022550243A5 JP2022506438A JP2022506438A JP2022550243A5 JP 2022550243 A5 JP2022550243 A5 JP 2022550243A5 JP 2022506438 A JP2022506438 A JP 2022506438A JP 2022506438 A JP2022506438 A JP 2022506438A JP 2022550243 A5 JP2022550243 A5 JP 2022550243A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antibody
- cdr
- seq
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910939944.8 | 2019-09-30 | ||
| CN201910939944 | 2019-09-30 | ||
| PCT/CN2020/116417 WO2021063201A1 (zh) | 2019-09-30 | 2020-09-21 | 抗pd-1抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550243A JP2022550243A (ja) | 2022-12-01 |
| JP2022550243A5 true JP2022550243A5 (enExample) | 2023-09-20 |
Family
ID=75337572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506438A Pending JP2022550243A (ja) | 2019-09-30 | 2020-09-21 | 抗ｐｄ－１抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240425593A1 (enExample) |
| EP (1) | EP4039704A4 (enExample) |
| JP (1) | JP2022550243A (enExample) |
| KR (1) | KR20220070201A (enExample) |
| CN (1) | CN114206931B (enExample) |
| WO (1) | WO2021063201A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4410835A4 (en) * | 2021-09-29 | 2025-09-24 | Akeso Biopharma Inc | ANTI-LAG3 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE |
| CN114835810B (zh) * | 2022-03-31 | 2024-01-05 | 浙江特瑞思药业股份有限公司 | 一种抗pd-1纳米抗体及其应用 |
| JP2025512031A (ja) * | 2022-04-14 | 2025-04-16 | ベイジーン スウィッツァーランド ゲーエムベーハー | Ｐｄ－１抗体を含有する安定した高濃度塩化ナトリウム製剤及びその使用方法 |
| CN115785269B (zh) * | 2022-11-01 | 2023-09-22 | 四川大学 | 抗pd-l1的抗体及其应用 |
| CN116854820B (zh) * | 2023-06-26 | 2024-02-06 | 华中科技大学同济医学院附属协和医院 | Pd-1非阻断性清除抗体及其用途 |
| CN119798436A (zh) * | 2023-10-10 | 2025-04-11 | 长春金赛药业有限责任公司 | 抗pd-1单克隆抗体及其应用 |
| CN118388648B (zh) * | 2024-04-16 | 2025-04-01 | 赛业（苏州）生物科技有限公司 | 一种基于全人源抗体鼠的人pd-l1抗体及其制备方法和应用 |
| WO2026041144A1 (zh) * | 2024-08-23 | 2026-02-26 | 百图生科(苏州)智能科技有限公司 | Pd-1激动性抗体及其用途 |
| CN120718149B (zh) * | 2025-06-26 | 2026-05-05 | 天津市中西医结合医院（天津市南开医院） | Pd-1抗体及其应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| USPP4816P (en) | 1980-09-11 | 1982-01-26 | Mikkelsens Inc. | Kalanchoe plant |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE60131456T2 (de) | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | Transchromosomale transgen-nagetiere zur herstellung von humanen antikörpern |
| CN104250302B (zh) * | 2013-06-26 | 2017-11-14 | 上海君实生物医药科技股份有限公司 | 抗pd‑1抗体及其应用 |
| KR102236367B1 (ko) | 2013-07-26 | 2021-04-05 | 삼성전자주식회사 | DARPin을 포함하는 이중 특이 키메라 단백질 |
| WO2015141862A1 (en) | 2014-03-17 | 2015-09-24 | Mitsubishi Tanabe Pharma Corporation | Antibody-fynomer conjugates |
| KR102524920B1 (ko) * | 2014-07-22 | 2023-04-25 | 아폴로믹스 인코포레이티드 | 항-pd-1 항체 |
| EP3218409A2 (en) * | 2014-11-11 | 2017-09-20 | Sutro Biopharma, Inc. | Anti-pd-1 antibodies, compositions comprising anti-pd-1 antibodies and methods of using anti-pd-1 antibodies |
| CN105061597B (zh) * | 2015-06-09 | 2016-04-27 | 北京东方百泰生物科技有限公司 | 一种抗pd-1的单克隆抗体及其获得方法 |
| MX383464B (es) * | 2015-07-13 | 2025-03-14 | Cytomx Therapeutics Inc | Anticuerpos anti-pd-1, anticuerpos anti-pd-1 activables, y métodos de uso de los mismos. |
| PE20231958A1 (es) * | 2015-07-30 | 2023-12-06 | Macrogenics Inc | Moleculas de union a pd-1 y metodos de uso de las mismas |
| RU2722451C1 (ru) * | 2015-09-29 | 2020-06-01 | Шанхай Чжанцзян Биотекнолоджи Ко., Лтд. | Pd-1 антитела и их применение. |
| CN107286242B (zh) * | 2016-04-01 | 2019-03-22 | 中山康方生物医药有限公司 | 抗pd-1的单克隆抗体 |
| CN106046162B (zh) * | 2016-06-21 | 2019-04-02 | 大庆东竺明生物技术有限公司 | 抗人程序性死亡因子1（pd-1）单克隆抗体的制备及应用 |
| CN107840887B (zh) * | 2016-09-21 | 2022-03-25 | 基石药业（苏州）有限公司 | 一种新的pd-1单克隆抗体 |
| CN106519034B (zh) * | 2016-12-22 | 2020-09-18 | 鲁南制药集团股份有限公司 | 抗pd-1抗体及其用途 |
| CN110366564B (zh) * | 2016-12-23 | 2023-07-07 | 瑞美德生物医药科技有限公司 | 使用与程序性死亡1(pd-1)结合的抗体的免疫疗法 |
| US11421029B2 (en) * | 2017-09-01 | 2022-08-23 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Recombinant bispecific antibodies to PD-L1 and CTLA-4 |
| AU2018366199A1 (en) * | 2017-11-08 | 2020-05-28 | Xencor, Inc. | Bispecific and monospecific antibodies using novel anti-PD-1 sequences |
| CN109467603B (zh) * | 2017-11-14 | 2020-02-21 | 拜西欧斯（北京）生物技术有限公司 | 抗pd-1抗体及其制备方法和应用 |
| WO2019141092A1 (zh) | 2018-01-18 | 2019-07-25 | 四川科伦博泰生物医药股份有限公司 | 抗lag-3抗体及其用途 |
| CN112236454B (zh) * | 2018-03-20 | 2022-09-13 | 上海药明生物技术有限公司 | 新型抗pd-1抗体 |
| US11884725B2 (en) | 2018-04-24 | 2024-01-30 | Ampsource Biopharma Shanghai Inc. | Antibody against TIM-3 and application thereof |
-
2020
- 2020-09-21 CN CN202080055788.XA patent/CN114206931B/zh active Active
- 2020-09-21 WO PCT/CN2020/116417 patent/WO2021063201A1/zh not_active Ceased
- 2020-09-21 KR KR1020227003770A patent/KR20220070201A/ko not_active Ceased
- 2020-09-21 US US17/631,799 patent/US20240425593A1/en not_active Abandoned
- 2020-09-21 JP JP2022506438A patent/JP2022550243A/ja active Pending
- 2020-09-21 EP EP20870685.3A patent/EP4039704A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6908722B2 (ja) | 抗ｐｄ−１抗体及びその使用 | |
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2024125370A (ja) | クローディン１８．２結合部分およびその利用 | |
| US12098210B2 (en) | Methods of treating cancers and enhancing efficacy of BCMAxCD3 bispecific antibodies | |
| JP2022515318A5 (enExample) | ||
| US20200093922A1 (en) | Anti-PD-L1 Antibodies | |
| TW201827464A (zh) | 人程序性死亡受體ｐｄ－１的單株抗體及其片段 | |
| CA3187442A1 (en) | Compositions including ex vivo armed t cells with multi-specific antibodies and uses thereof | |
| JPWO2018117237A1 (ja) | 抗ｃｄ３抗体及び該抗体を含む分子 | |
| JP7328324B2 (ja) | Ｔｉｍ－３に対する抗体およびその使用 | |
| WO2021063201A1 (zh) | 抗pd-1抗体及其用途 | |
| CA3192256A1 (en) | Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphoma | |
| KR20240069787A (ko) | 항체 표적화 baff-r 및 이의 사용 | |
| JP2024540148A5 (enExample) | ||
| JP2022532991A5 (enExample) | ||
| JP2025537692A (ja) | 癌を治療する方法 | |
| WO2023125289A1 (zh) | 抗pd-1抗体及其用途 | |
| JP7811028B2 (ja) | ヒトｃｘｃｌ１６抗体およびその使用 | |
| JP2024508597A5 (enExample) | ||
| CN118076641A (zh) | 抗cd26抗体及其应用 | |
| JP2024540062A5 (enExample) | ||
| TW202146446A (zh) | 一種抗pd-l1和egfr的四價雙特異性抗體 | |
| JP2023513800A5 (enExample) | ||
| CN106963950B (zh) | 用于治疗肿瘤的联合用药物 | |
| CN116199777B (zh) | 抗hNKG2D抗体及其应用 |